September 4, 2015
Doctor's attempt to bring lower-price diabetes drug to market thwarted
Davidson cited a recent paper in the Journal of the American Medical Assn. showing that prices of both generic and patented insulins have jumped more than 500% since 2001. The cost of a vial of one of the most commonly used fast-acting insulins, Humalog, soared to $234 this year from $35 in 2001, the journal said.
Oops. Did I really say that drug companies need our support? My bad. I meant to say that drug companies need our life support! Huge difference. Sorry about that.
Do you know what else I meant to say? Well, it rhymes with fun of a witch! Bass wholes! Druther buckers! Whoosh rags! Sigh.
Q2 GDP Tracking: Mid-2s
-
From BofA:
Since our last weekly publication, our 2*Q GDP tracking is down one-tenth
to 2.2% q/q saar*. [July 18th estimate]
emphasis added
From Goldman:...
4 hours ago
No comments:
Post a Comment